Last November, Pyxis revealed it would continue to focus on PYX-201 as its lead asset, while pausing other early-stage ...
Protects the use of onvansertib in combination with standard of care in the KRAS mutated mCRC setting through 2043 - SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRDF), a clinical-stage ...
Hosted on MSN19h
Lung cancer symptoms in people who've never smoked - and how it's different in smokersPersonalized treatment alternatives focusing on particular molecular alterations linked to nonsmoker lung cancer have been devised by scientists. For instance, adenocarcinoma, which tends to grow ...
Researchers at the University of Southern California have found that a synthetic chemical widely present in the environment ...
That’s what my dad, Tony, said to me as he came out of what would be his final appointment with the oncologist in August 2023 ...
"The patients in the study have endured multiple rounds of therapy before treatment with PYX-201 ... in patients with 1L and ...
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced positive topline results from the pivotal ...
These include a drug delivery platform for the treatment of peritoneal cancer, which resulted in the spin-off company NaDeNo. And today, a new cure for lung cancer is on the researchers' agenda.
Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...
A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback